| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |